American Heart Journal
Volume 157, Issue 3 , Pages 412-422, March 2009

Facts and controversies of aspirin and clopidogrel therapy

  • David P. Faxon, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, MA
    • Corresponding Author InformationReprint requests: David P. Faxon, MD, Harvard Medical School, Brigham & Women's Hospital, Department of Medicine, 0BC3 – Room 012P, 1620 Tremont Street, Boston, MA 02120.
    • ,
  • Jane E. Freedman, MD

      Affiliations

    • Division of Cardiology, Boston University School of Medicine, Boston, MA

Received 25 April 2008; accepted 25 November 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0002-8703(08)01042-9

doi:10.1016/j.ahj.2008.11.019

American Heart Journal
Volume 157, Issue 3 , Pages 412-422, March 2009

Article Tools

* Image Usage & Resolution